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ttp://dx.doi.org/10.1016/j.ajpath.2013.11.013McLeod neuroacanthocytosis syndrome (MLS) is a rare X-linked multisystem disease caused by XK gene
mutations and characterized by hematological and neurological abnormalities. XK, a putative membrane
transporter, is expressed ubiquitously and is covalently linked to Kell, an endothelin-3-converting
enzyme (ECE-3). Absence of XK results in reduction of Kell at sites where both proteins are coex-
pressed. To elucidate the functional roles of XK, Kell, and the XKeKell complex associated with
pathogenesis in MLS, we studied the pathology of the spinal cord, anterior roots, sciatic nerve, and
skeletal muscle from knockout mouse models, using Kel/, Xk/, Kel/Xk/, and wild-type mice
aged 6 to 18 months. A striking ﬁnding was that giant axons were frequently associated with paranodal
demyelination. The pathology suggests probable anterograde progression from the spinal cord to the
sciatic nerve. The neuropathological abnormalities were found in all three genotypes, but were more
marked in the double-knockout Kel/Xk/ mice than in either Kel/ or Xk/ mice. Skeletal muscles
from Xk/ and Kel/Xk/ mice showed mild abnormalities, but those from Kel/ mice were similar
to the wild type. The more marked neuropathological abnormalities in Kel/Xk/ mice suggest
a possible functional association between XK and Kell in nonerythroid tissues. (Am J Pathol 2014,
184: 800e807; http://dx.doi.org/10.1016/j.ajpath.2013.11.013)Supported by NIH grant R01 HL075716 (S.L.).
Disclosures: None declared.McLeod neuroacanthocytosis syndrome (MLS) is a rare, X-
linked multisystem disorder associated with the McLeod
phenotype due to mutations in the XK gene. MLS typically
presents in middle age, with central nervous system, neu-
romuscular, cardiac, and hematological manifestations.
Abnormalities include acanthocytosis, cardiomyopathy,
degeneration of the basal ganglia, and sensorimotor neurop-
athy. Central nervous system manifestations include chorea
and cognitive and psychiatric abnormalities similar to those
seen in Huntington disease.1e3 Acanthocytosis accompanied
by compensated hemolysis and a variable reaction to
incompatible transfusion may occur because of the McLeod
blood-group phenotype. Neurodegeneration affects mainly
the caudate nucleus, although functional neuroimaging
demonstrates more general striatal pathology, with decreased
dopamine D2 receptor binding, decreased [
18F]ﬂuorodeox-
yglucose uptake, and caudate hypoperfusion. Neuromuscularstigative Pathology.
.manifestations include sensorimotor axonopathy, as well as
myopathy with elevated creatine kinase. Histopathological
studies indicate axonal degeneration of the sural nerve and
neurogenic atrophy in most muscle studies, with ﬁber at-
rophy in some cases. Additional nonspeciﬁc changes
include internalized nuclei and variation in muscle ﬁber
sizes.4
The putative membrane transporter XK, a member of the
XK family, is expressed ubiquitously. It is linked to the
endothelin-3-converting enzyme Kell via a single disulﬁde
bond when they are coexpressed (eg, in red blood cells). In-
sights into XKeKell function can be gained from XK binding
to the 4.1R protein. Linked to Kell, XK binds to the a-lobe (B
lobe, middle lobe) of the FERM domain of protein 4.1R,
Table 1 Frequency of Giant Axons and/or Paranodal Demyelin-







 þ þþ þþþ
Nonexercised mice
WT 17 6 4 2 0 0
Xk/ 17 4 1 0 1 2
Kel/ 12 5 1 1 0 3
Kel/ 17 3 0 0 0 0
Kel/Xk/ 17 6 0 0 0 6
Exercised mice
WT 18 1 0 1 0 0
Xk/ 18 3 0 0 0 3
*Scoring is based on 10 randomly selected high-power ﬁelds. , absence
of giant axons;þ, 1 giant axons and/or paranodal demyelination;þþ, 2 to
3 giant axons and/or paranodal demyelinations; þþþ, 4 giant axons
and/or paranodal demyelinations.
Giant Axons in Mouse Models of MLSwhich itself binds to b-spectrin at the binding junction of
spectrin and actin, forming a 4.1Respectrineactin ternary
complex of cytoskeleton in erythrocytes.5e8
Although Kell and XK are covalently linked on red
blood cells, where each protein appears to be expressed in
equal amounts, XK is expressed in relatively large
amounts in nonerythroid tissues, such as skeletal muscle
and brain.9e12 In contrast, Kell is largely restricted to
erythroid tissues, although a small amount is expressed in
nonerythroid tissues such as spinal cord and probably in
speciﬁc functional cells in brain.11,13,14 The expression of
Kell and XK in red blood cell membranes is closely
linked; when Kell is absent, XK is reduced, and vice
versa. In human skeletal muscle, XK is expressed in type
2 ﬁbers.15
To study the physiological functions of Kell and XK, and
their interactions, Kel/, Xk/, and double-knockout
Kel/Xk/ mice have been produced.13,16 In studies
with erythrocytes from these sets of knockout mice, Kell
and XK proteins were recently shown to be functionally
coupled with divalent cation transport systems.13,16 In the
present study, we investigated the pathological features of the
neuromuscular system in Kel/, Xk/, and Kel/Xk/
mice, to elucidate the underlying pathophysiology of neuro-
muscular symptoms in MLS patients.
Materials and Methods
Mice
Targeted gene disruption was used to establish female Kel/
129/SvJ mice and male Xk/y 129/SvJ mice. The targeting
constructs, gene targeting methods, and characterization of
the Kel/ and Xk/y mice were as described previously by
Zhu et al13 and Rivera et al.16 To produce knockout mouse
lines on a C57BL/6 congenic background, female Kel/
and male Xk/y mice were mated to C57BL/6 mice, pur-
chased from Charles River Laboratories International
(Wilmington, MA), and backcrossed for 10 generations.
Wild-type (WT) mice were obtained by breeding N10 het-
erozygous or hemizygous offspring. N10 male Kel/ and
female Xk/ mice were mated to produce N11 female Kelþ/
Xkþ/ and male Kelþ/Xk/y mice. These mice were mated
to produce a double-knockout Kel/Xk/ mouse line. All
mice used in this study were on a C57BL/6 congenic
background. All animals were housed and handled accord-
ing to protocols approved by the institutional animal care
and use committee at the New York Blood Center. At least
three mice from each of four different age groups were used
for histopathological studies from three different experi-
mental genotypes (knockout mouse lines) and WT mice.
The age groups studied ranged from 6 to 18 months. Xk/
mice (nZ 7) and matching WT mice (nZ 8), aged 10 to 18
months, were housed individually for 5 to 7 months in cages
with exercise wheels connected to a digital magnetic counter
activated by wheel rotation.The American Journal of Pathology - ajp.amjpathol.orgPathology
All mice were weighed. After deep anesthesia using isoﬂurane
(USP) (Baxter Healthcare, Deerﬁeld, IL), mice were trans-
cardially perfused with PBS for 10 minutes, which was fol-
lowed by 4% paraformaldehyde perfusion. Brain, spinal cord
with attached spinal roots, and bilateral sciatic nerves were
removed. Parts of the sciatic nerves and lumbar spinal cord
were ﬁxed in 3% glutaraldehyde in 0.1 mol/L sodium caco-
dylate buffer (pH 7.3) for electron microscopy. The remainder
of the sciatic nerve and spinal cord tissue was further ﬁxed in
4% paraformaldehyde for parafﬁn embedding. During PBS
perfusion, the gastrocnemius, quadriceps femoris, and triceps
brachii muscles were isolated, snap-frozen in isopentane pre-
chilled with liquid nitrogen, and stored at 80C.
After parafﬁn embedding, cross sections (8 mm) were cut
from the cervical enlargement, midthoracic segment, and
lumbar enlargement and were stained with H&E. Sciatic
nerves were sectioned (5 mm thick) and stained with H&E.
Cryosections (5 mm thick) of gastrocnemius, quadriceps
femoris, and triceps brachii muscles were stained with H&E
and modiﬁed Gömöri trichrome stain. Skeletal muscles were
stained with NADHetetrazolium reductase, ATPases (pH
4.6 and pH 9.4), nonspeciﬁc esterase, and acid phosphatase,
according to standard methods.
Sections (1 mm thick) were cut from eponate-embedded
tissue and stained with Toluidine Blue and counterstained
with safranin. Cross sections of the ventral quarter of spinal
cord and both cross sections and longitudinal sections of
anterior roots were obtained from 28 mice, including 21
knockout mice (Table 1). Sciatic nerves were obtained from
38 mice, including 25 knockout mice (Table 2). From these,
7 knockout and 4 WT mice were selected for further study
by electron microscopy. Ultrathin sections (80 nm thick)
were stained with uranyl acetate and lead citrate for exam-
ination using an EM-410 transmission electron microscope
(Philips, Amsterdam, The Netherlands).801
Table 2 Frequency of Giant Axons and/or Paranodal Demyelination in the Sciatic Nerve
Genotype and
condition





 þ þþ þþþ  þ þþ þþþ
Nonexercised 17 months 6e12 months
WT 7 6 1 0 0 4 4 0 0 0
Xk/ 4 2 2 0 0 3 3 0 0 0
Kel/ 2 1 0 1 0 3 3 0 0 0
Kel/Xk/ 5 2 2 1 0 4 4 0 0 0
Exercised 16e19 months 10 months
WT 1 1 0 0 0 1 1 0 0 0
Xk/ 2 1 0 1 0 2 1 1 0 0
*Scoring as deﬁned for Table 1, except based on one cross section of sciatic nerve.
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Spinal Cord, Ventral Roots, and Sciatic Nerves
The most striking change seen on 1-mm-thick sections
stained with Toluidine Blue was the presence of giant axons
in the sciatic nerve and in the anterior column of the spinal
cord (Figures 1 and 2). The giant axons were of various
sizes and contained mostly pale, homogeneous axoplasm.
Occasionally, they contained irregularly distributed
osmium-dense particles (Figures 1E and 2E). The myelin
sheaths of most giant axons were thinner than expected from
their diameter on cross sections (Figures 1C and 2B). On
longitudinal sections, the thickness of myelin sheaths was
frequently irregular over the length of an internode and
exhibited paranodal demyelination, with an extended gap in
the myelin sheath between internodes (Figures 1D and 2DFigure 1 Giant axons (arrows) in mouse sciatic nerve. A: Transverse section (
Large axons with thin myelin sheath from longitudinal section (Xk/). D: A port
(Xk/). E: Large axon with disrupted myelin sheath and unevenly distributed o
sheath (Xk/). Sections are 1 mm thick. Toluidine Blue stain. Original magniﬁca
802and 2F). In addition to the giant axons, a few small nerve
ﬁbers were surrounded by thicker myelin sheaths than ex-
pected from their diameters (Figure 1F).
Ultrastructurally, most giant axons had thinner myelin
sheaths than expected from their diameters (Figure 3, A
and B) and were ﬁlled with irregularly bundled neuro-
ﬁlaments (NFs) (Figure 3C). Microtubules and other or-
ganelles were sparsely dispersed among the bundles of
NFs (Figure 3, DeF). Other ﬁndings included clustering
of microtubules, dense lamellar bodies, and membranous
vesicles, as well as membranous structures involving the
adaxon of Schwann cells, which may indicate adaxonal
degeneration of Schwann cells (Figure 3, G and H). As in
the 1-mm-thick sections examined under light microscopy,
occasional small axons had thicker myelin sheaths than
expected (Figure 3I).WT). B: Large demyelinated axon from transverse section (Kel/Xk/). C:
ion of an internode with partial demyelination from a longitudinal section
smium-dense material (Kel/Xk/). F: Atrophic axon with thick myelin
tion, 1000.
ajp.amjpathol.org - The American Journal of Pathology
Figure 2 Giant axons (arrows) in the anterior column and ventral root of mouse spinal cord. A: Transverse section of the anterior column (from WT mice). B:
Several large axons with relatively thin myelin sheaths on a transverse section of anterior column (Kel/). C and D: Irregular thickness of myelin sheath with
paranodal demyelination and partial detachment of myelin leaﬂets in a longitudinal section of the ventral root [Kel/Xk/ (C) and Kel/ (D)]. E: Enlarged
axon packed with osmium-dense particles and vacuoles with partial disruption of myelin sheath from a longitudinal section of the ventral root (Kel/). F:
Paranodal demyelination from a longitudinal section of the ventral root of exercised mice (Xk/). Sections are 1 mm thick. Toluidine Blue stain. Original
magniﬁcation, 1000.
Giant Axons in Mouse Models of MLSThe density of giant axons was clearly higher in the
anterior column of the spinal cord, especially in the subpial
zone, relative to that of the sciatic nerve.
All three genotypes had giant axons of similar appear-
ance, but giant axons were more frequent in Kel/Xk/
mice than in Kel/ or Xk/ (Tables 1 and 2). Although the
number of mice in each group was small, there was an
appreciable tendency toward more giant axons in older
mice, and in exercised mice (Tables 1 and 2). WT mice also
had occasional large axons, but these were of smaller
diameter than in experimental animals, and all had myelin
sheaths of normal thickness (ie, as expected from their di-
ameters) (Figure 2A).
Skeletal Muscle
In young Xk/, Kel/, and Xk/Kel/ mice, it was hard
to discern any obvious pathology. Skeletal muscles in older
Xk/ and Xk/Kel/ mice were clearly abnormal, with
variation in muscle ﬁber sizes, frequent internalized nuclei
(Figure 4D), occasional muscle ﬁber splitting, and atrophic
ﬁbers (Figure 4, BeD). Atrophic ﬁbers were mostly angu-
lated and singly scattered among other ﬁbers (Figure 4,
BeD). Occasional angulated atrophic ﬁbers found in all
experimental genotypes had diffusely basophilic sarcoplasm
with a faintly ﬂuffy quality to it (Figure 4C). There was no
necrosis in any genotype, but regenerating ﬁbers were oc-
casionally noted in exercised Xk/ mice (Supplemental
Tables S1 and S2). No endomysial ﬁbrosis was noted,
and there was no ﬁber-type atrophy. Angulated ﬁbersThe American Journal of Pathology - ajp.amjpathol.org(Supplemental Table S1) and internalized nuclei
(Supplemental Table S2) were frequently present in Xk/
mice (to a greater extent in Xk/Kel/ mice, and most
frequently in exercised Xk/ mice). The ﬁndings in Kel/
mice did not differ signiﬁcantly different from those in WT.
Discussion
Greater numbers of giant axons with varying degrees of para-
nodal demyelination were observed in the anterior column of
the spinal cord and ventral roots of spinal nerve in all three lines
of knockout mice, compared with WT mice. Giant axons
typically result from disturbances in function or structure of
NFs, which are a major component of vertebrate neural cyto-
skeleton and are associatedwith axonal transport.Disruption of
NF architecture at many levels can result in giant axon for-
mation due to NF accumulation. Giant axonopathy, which has
been described in many unrelated conditions, is the apparent
end result of various toxic and metabolic derangements.17e20
The histopathological features observed in the present study
are similar to drug-induced nerve damage caused by iminodi-
propionitrile,21 doxorubicin (Adriamycin),22 quelamycin,23 or
vincristine,24 in which axoplasmic disturbance induced accu-
mulation of NF, leading to formation of giant axons. NF
accumulation is also found in amyotrophic lateral sclerosis.25,26
In Xk/ and Kel/ mice, giant axonal changes were
more prominent in the spinal cord than in sciatic nerve,
suggesting anterograde progression of the pathological
features. In iminodipropionitrile-induced damage, giant
axons with NF accumulation are caused by the disruption of803
Figure 3 Ultrastructural details of giant axons in spinal cord and sciatic nerve. A: Giant axon with an extremely attenuated myelin sheath in the anterior column
of the spinal cord (Kel/Xk/). B: Giant axon with an extremely attenuatedmyelin sheath in the sciatic nerve (Xk/). C: Giant axon with irregular accumulation of
NFs and apparent absence of other organelles in the sciatic nerve (Xk/). D: Giant axon with a thin myelin sheath containing irregularly arranged NFs and sparsely
scattered microtubules in the anterior column of the spinal cord (Kel/Xk/). E: Segregation of microtubules from NFs on a cross section of the sciatic nerve
(Kel/Xk/). F: Irregularly dispersed microtubules in the anterior column of the spinal cord (Kel/). G: Accumulation of dense lamellar bodies and membranous
vesicles indicating axonal degeneration in the anterior column of the spinal cord (Kel/Xk/).H:Membranous structures involving the adaxon of a Schwann cell in
the anterior column of the spinal cord (Kel/). I: Atrophic axon with contracted axon surrounded by a thick myelin sheath containing osmium-dense particles in the
sciatic nerve of Kel/Xk/ mice. Symbols: opposing arrows, thin or absent MS; short black arrow or black star, NF; long black arrow, MV; black arrowhead or
white star, MT; white arrow, DLB. Sections are 80 nm thick. Scale bars: 2 mm (A, B, and I); 500 nm (CeH). DLB, dense lamellar body; M, mitochondria; MS, myelin
sheath; MT, microtubule; MV, membranous vesicles; SciN, sciatic nerve; SpAC, anterior column of the spinal cord.
Zhu et alside-arms connecting NFs and microtubules.21 Furthermore,
NFs are closely associated with aII/bII-spectrin (non-
erythroid spectrin, or fodrin) in vivo5e7 and bIIS1-spectrin
interacts with NF light-chain (NF-L) proteins in vitro, and
similarly with actin.27 aII Spectrin is involved in the para-
nodal complex that links axoeglial junctions to axonal
cytoskeleton.28 Therefore, XK may interact with the spec-
trineactin cytoskeletal complex through binding to
4.1R,5e7,29 and may associate with the NF-L network in
axons and be involved in axonal transport. XK may interact804directly or indirectly with NFs, particularly with NF-L.
Absence of XK may be one of the mechanisms for distur-
bance of the slow component of axonal transport, NF
accumulation, and the resultant giant axon formation in Xk/
mice. These neuropathological ﬁndings correlate with the
ﬁndings of motor abnormalities indicative of peripheral
neuromuscular dysfunction for Kel/ mice.13
Disruption of ion homeostasis due to dysfunction of the
4.1R protein subcomplex in the absence of XK may be one
of the causes of paranodal demyelination and may alsoajp.amjpathol.org - The American Journal of Pathology
Figure 4 Skeletal muscle abnormalities. A: WT quadriceps femoris. B
and C: Triceps brachii with angulated ﬁbers (black arrows) of Kel/Xk/
(B) and Xk/ (C) mice. D: Quadriceps femoris of Xk/ exercised mice with
angulated ﬁbers (black arrows) and internalized nuclei (white arrow). H&E
stain. Sections are 5 mm thick. Original magniﬁcation: 200 (A, B, and D);
400 (C).
Giant Axons in Mouse Models of MLSaffect axonal transport, leading further to giant axon for-
mation. The XK-binding FERM domain of 4.1 proteins is a
recruiter of many functional proteins, including ion trans-
porters and proteins involved in signal transduction, forming
a cytoskeletonemembrane regulatory macrocomplex.30
Ex vivo studies of the physiological function of XKeKell
complex using Xk/, Kel/, and Kel/Xk/ mice have
shown that XK and Kell are associated with cation transport
systems involved in ion homeostasis and that Kell may
control XK, either directly or indirectly.16
Although giant axons have not been reported in patients
with MLS, the nonspeciﬁc ﬁndings found on sural nerve
biopsy of minimal axonal neuropathy with ﬁbrosis and ev-
idence of active degeneration4,31,32 are consistent with
changes in the distal portion of a nerve in which there is
proximal giant axonopathy. Axonal degeneration is an ex-
pected consequence of failure of orderly axoplasmic ﬂow.33
If a similar pathological process occurs in MLS patients,
negative electrodiagnostic ﬁndings would be expected early
in the course of MLS, unless the study includes the proximal
loop of the circuit (H reﬂex, but this is not routinely per-
formed). Although elevated creatine kinase, usually inter-
preted as an indication of muscle damage (primary
myopathy), is typically observed during the asymptomatic
phase in MLS patients,34 muscle weakness may be the result
of conduction blockage due to paranodal demyelination,
rather than to primary myopathy. This may also explain the
lack of pathological changes in muscle biopsy early in the
disease course, whereas biopsies from patients with longer-
term disease show evidence of neurogenic atrophy.4
Muscle abnormalities were readily recognizable in Xk/
mice, still more evident in Kel/Xk/ mice, and most
abundant in exercised Xk/ mice. In contrast, there was noThe American Journal of Pathology - ajp.amjpathol.orgobvious pathology in the muscles of Kel/ mice. Kell and
XK proteins in human skeletal muscle differ in both
amount12,14 and distribution.15 XK is abundant and present
in sarcoplasmic membranes conﬁned to the sarcoplasmic
reticulum, as indicated by a distinctive honeycomb-like
pattern of anti-XK immunoreactivity in type 2 ﬁbers.
These type 2 ﬁbers are atrophic in MLS.15 Kell is present at
much lower levels than XK, and is present in sarcolemma.
The excess XK could exist either as a monomer or coupled
with a protein other than Kell. Because multiple isoforms of
4.1R are known to be present in skeletal muscles,35 it is
plausible that XK binds to 4.1R or to other 4.1 proteins as
part of a large protein complex. In brain, the 4.1R isoform
and 4.1G bind with a fodrineF-actin complex.36
In human MLS, mixed neuropathic and myopathic ab-
normalities are observed.1,4 Although the giant axons that
we observed indicated neuropathy, the muscle ﬁndings seen
in Xk/ and Kel/Xk/ mice (eg, weak nonspeciﬁc
esterase staining and absence of ﬁber-type grouping) were
more consistent with myopathy.
The muscle weakness and atrophy of MLS patients in-
creases with advancing disease,1,4 which is consistent with
our ﬁndings in younger versus older mice. In humans, the
disease affects mainly the lower limbs and is more pro-
nounced distally1,4 (as is typical of neuropathic diseases in
which the longest axons are most vulnerable), which differs
from our present ﬁndings of more proximal involvement.
Our data showing giant axon formation with different de-
grees of paranodal demyelination of sciatic nerve and
lumbar spinal cord are consistent with muscle weakness and
generalized areﬂexia indicative of peripheral nervous sys-
tem involvement.1,4
Ultimately, the critical factor in MLS and the role of the
KelleXK complex in pathogenicity remain unknown. Our
neuropathology data demonstrate the presence of giant axons
in both Xk/ and Kel/ mice, which is more marked in
Kel/Xk/ mice, suggesting a possible structural and
functional association of Kell and XK in neuronal cells, as
has been demonstrated in red blood cells.16 The importance
of the KelleXK complex in neuronal cells can be predicted
based on the evolutionary patterns of the Kell system
involving signaling pathways through Kell (with endothelin-
3-converting enzyme activity)eendothelin-3 (ET-3)eendo-
thelin receptor B. Kell appeared in warm-blooded vertebrates
later37 than did XK,38,39 and linked to the pre-existing
vertebrate gene product XK apparently to modify its func-
tion. This signaling path is the most recent addition to the pre-
existing endothelin systems and may control the role of the
functional protein subunit at the 4.1Respectrineactin
ternary complex, either by a direct effect on XK or indirectly
through proteins in the 4.1R functional protein subunit.16 If
this ET-3 signaling path is the object of Kell in the KelleXK
complex, then a reduced level of Kell in absence of XK will
have a critical role in MLS. Critical evaluation of this protein
subunit as a one functional unit may be required. The dearth
of information regarding tissue and cellular expression of805
Zhu et alKell and XK has hampered studies of the pathophysiology of
MLS. Critical evaluations of XK and Kell and the proteins
associated with these two proteins, such as in the 4.1R sub-
unit of functional protein complex in the cytoskeleton, may
provide valuable insights.
Humans without Kell (Kell-null red blood cell pheno-
type) appear to be clinically normal, although no neuro-
muscular pathological studies of such subjects have yet been
reported. This species difference may be due to differences
between human and mouse Kell, although the proteins have
functional and structural similarities (74% amino acid
sequence identity), in addition to the inherent bio-
physiological differences between human and mouse. For
example, both mouse and human Kell proteins have sub-
strate preference for big ET-3, but the preference of human
Kell for big ET-3 appears to be stronger than that of mouse
Kell, and mouse Kell has a greater ability to cleave big ET-1
and big ET-2 showing higher redundancy.40,41
In conclusion, Kel/, Xk/, and Kel/Xk/ mice
exhibit pathological changes that could explain some of the
neuromuscular symptoms in MLS patients. These knockout
mouse models could be informative for further in-
vestigations into the underlying mechanisms of the patho-
logical features of MLS, and also in choreaeacanthocytosis,
which is a genetically distinct but phenotypically similar
neuroacanthocytosis syndrome that similarly manifests with
acanthocytosis and basal ganglia degeneration.42,43
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